Imaging biomarkers for detection and longitudinal monitoring of ventricular abnormalities from birth to childhood.

Abstract

This narrative review examines the use of imaging biomarkers for diagnosing and monitoring hydrocephalus from birth through childhood. Early detection and longitudinal follow-up are essential for guiding timely interventions and assessing treatment outcomes. Cranial ultrasound and magnetic resonance imaging (MRI) are the primary imaging modalities, providing critical insights into ventricular size, cerebrospinal fluid dynamics, and neurodevelopmental implications. Key parameters, including Evans' index, Levene's index, and the Cella Media index, as well as volumetric and diffusion-based MRI techniques, have been explored for their diagnostic and prognostic value. Advances in automated image analysis and artificial intelligence have further improved measurement precision and reproducibility. Despite these developments, challenges remain in standardizing imaging protocols and establishing normative reference values across different pediatric populations. This review highlights the strengths and limitations of current imaging approaches, emphasizing the need for consistent methodologies to enhance diagnostic accuracy and optimize patient management in hydrocephalus.